Abstract
Stroke remains a leading cause of death and long-term disability in the developed world. Reperfusion and anti-thrombotic therapies are of limited benefit for the majority of patients following acute ischemic stroke, and increasing interest has focused on therapeutic approaches that seek to modulate infarct evolution. Animal and human studies have linked hyperglycemia in the acute phase of ischemic stroke to worse clinical outcomes regardless of the presence of pre-existing diabetes mellitus. Experimental data suggest that elevated blood glucose may directly contribute to infarct expansion through a number of maladaptive metabolic pathways, and that treatment with insulin may attenuate these adverse effects. In this review, we analyze the relationship between elevated serum glucose and acute cerebrovascular ischemia, and critically appraise the potential of a clinical strategy that targets euglycemia in all acute stroke patients.
This is a preview of subscription content, access via your institution.
References
- 1.
Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med 2000;343:710–722.
- 2.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035–2038.
- 3.
Toni D, Sacchetti ML, Argentino, C, et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol 1992;239:382–386.
- 4.
Olsson T, et al. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia 1990;33:244–249.
- 5.
Capes SE, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426–2432.
- 6.
Malmberg K, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: longterm results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626–2632.
- 7.
Gray CS, et al. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age and Ageing 2004;33:71–77.
- 8.
Kiers L, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992;55:263–270.
- 9.
Weir CJ, et al. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997;314:1303–1306.
- 10.
Jorgensen H, et al. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994;25:1977–1984.
- 11.
van Kooten F, et al. Hyperglycemia in the acute phase of stroke is not cuased by stress. Stroke 1993;24:1129–1132.
- 12.
Murros K, et al. Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction, J Neurol Sci 1992;111:59–64.
- 13.
Murros K, Fogelholmd R. Diabetes and stress hyperglycaemia in stroke. J Neurol Neurosurg Psychiatry 1993;56:428.
- 14.
Woo E, et al. Hyperglycemia is a stress response in acute stroke. Stroke 1988;19:1359–1364.
- 15.
O'Neill PA, et al. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 1991;22:842–847.
- 16.
Myers RE, Yamaguchi S. Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Arch Neurol 1977;34:65–74.
- 17.
Pulsinelli WA, et al. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982;32:1239–1246.
- 18.
Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab 1999;19:288–297.
- 19.
Lin B, Ginsberg MD, Busto R.. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations. Acta Neuropathol (Berl) 1998;96:610–620.
- 20.
de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE, et al. Fatal strokes in hyperglycemic cats. Stroke 1989;20:1707–1715.
- 21.
de Courten-Myers G, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 1988;19:623–630.
- 22.
Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R, et al. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 1988;8:186–192.
- 23.
Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD, et al. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke 1987;18:570–574.
- 24.
Helgason CM. Blood glucose and stroke. Stroke 1988;19:1049–1053.
- 25.
Nedergaard M, Gjedde A, Diemer NH. Hyperglycaemia protects against neuronal injury around experimental brain infarcts. Neurol Res 1987;9:241–244.
- 26.
Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurology 1998;51:S39-S43.
- 27.
Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995;82:262–268.
- 28.
Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metab 1991;11:1006–1014.
- 29.
Voll CL, Whishaw IQ, Auer RN. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. Stroke 1989;20:646–651.
- 30.
Wass CT, Scheithauer BW, Bronk JT, Wilson RM, Lanier WL, et al. Insulin treatment of corticosteroid-associated hyperglycemia and its effect on outcome after forebrain ischemia in rats. Anesthesiology 1996;84:644–651.
- 31.
Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab 1994;14:237–242.
- 31a.
Scott JF, Robinson GM, French JM, O'Connell JE, Alberti K, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The glucose in sulin in stroke trial (GIST). Stroke 1999;30:793–799.
- 32.
Siesjo BK, Katsura KI, Kristian T, Li PA, Siesjo P, et al. Molecular mechanisms of acidosis-mediated damage. Acta Neurochir Suppl 1996;66:8–14.
- 33.
Anderson RE, Tan WK, Martin HS, Meyer FB, et al. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999;30:160–170.
- 34.
Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC, et al. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Res 1999;821:467–479.
- 35.
Kraig RP, Petito CK, Plum F, Pulsinelli WA, et al. Hydrogen ions kill brain at concentrations reached in ischemia. J Cereb Blood Flow Metab 1987;7:379–386.
- 36.
Petito CK, Kraig RP, Pulsinelli WA, Light and electron microscopic evaluation of hydrogen ion-induced brain necrosis. J Cereb Blood Flow Metab 1987;7:625–632.
- 37.
Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 1991;3:213–245.
- 38.
Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS, et al. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000;31:183–192.
- 39.
Nedergaard M. Spleading depression as a contributor to ischemic brain damage. Adv Neurol 1996;71:75–84.
- 40.
Koistinaho J, Pasonen S, Yrjanheikki J, Chan PH, et al. Spreading depression-induced gene expression is regulated by plasma glucose. Stroke 1999;30:114–119.
- 41.
Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI, et al. Insulin resistance and risk for stroke. Neurology 2002;59:809–815.
- 42.
Kawai N, Keep RF, Betz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Acta Neurochir Suppl 1997;70:27–29.
- 43.
Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230–1239.
- 44.
Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155–158.
- 45.
Kawai N, Keep RF, Betz AL. Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir Suppl 1997;70:34–36.
- 46.
Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993;24:111–116.
- 47.
de Courten-Myers GM, Kleinholz M, Holm P, et al. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg, Med 1992;21:120–126.
- 48.
Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583–609.
- 49.
Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–426.
- 50.
Parsons MW, Barber PA, Desmond M, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20–28.
- 51.
Ginsberg MD. Hyperglycemia and stroke outcome: vindication of the ischemic penumbra. Ann Neurol 2002;52:5–6.
- 52.
Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–1610.
- 53.
Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activatorrelated intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30:34–39.
- 54.
Lindsberg PJ, Kaste M. Thrombolysis for acute stroke. Curr Opin Neurol 2003;16:73–80.
- 55.
Lindsberg PJ, Soinne L, Roine RO, et al. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke 2003;34:1443–1449.
- 56.
Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669–674.
- 57.
Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Stroke 2003;34:1235–1241.
- 58.
Bruno A, Biller J, Adams HP, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52:280–284.
- 59.
Christensen H, Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol 2002;9:297–301.
- 60.
Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke, 2003;34:2208–2214.
- 61.
Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67–71.
- 62.
Adams HP, Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–1083.
- 63.
Hack W, Kaste M, Bogousslavsky J, et al. European Stroke Initiative recommendations for stroke management-update 2003. Cerebrovasc Dis 2003;16:311–337.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gilmore, R.M., Stedd, L.G. The role of hyperglycemia in acute ischemic stroke. Neurocrit Care 5, 153–158 (2006). https://doi.org/10.1385/NCC:5:2:153
Issue Date:
Key Words
- Hyperglycemia
- stroke, insulin, diabetes mellitus